IRMD logo

IRadimed (IRMD) EBITDA

Annual EBITDA

$21.96 M
+$1.16 M+5.60%

December 31, 2024

Summary

Performance

1-Year Change

+5.6%

3-Year Change

+95.69%

5-Year Change

+122.1%

15-Year Change

+746.85%

IRMD EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

83.05%
IRMD annual EBITDA is higher than 83.05% of companies in Healthcare sector

High & Low

All-time High

$21.96 M
IRMD annual EBITDA is currently at an all-time high

3-Year Low

$11.22 M
IRMD annual EBITDA is currently +95.69% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
IRMD previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
IRMD next annual earnings announcement has not yet been scheduled

OtherIRMDprofitabilitymetrics:

Annual Revenue

$73.24 M
IRMD annual revenue is $73.24 million

Annual Net Income

$19.23 M
IRMD annual net profit is $19.23 million

Annual EBIT

$21.96 M
IRMD annual earnings before interest & taxes is $21.96 million

Annual EPS

$1.50
IRMD annual earnings per share is $1.50

Quarterly EBITDA

$5.80 M
-$186.50 K-3.12%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

IRMD Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

81.07%
IRMD quarterly EBITDA is higher than 81.07% of companies in Healthcare sector

High & Low

All-time High

$6.10 M
IRMD quarterly EBITDA is currently -4.84% below its historical high of $6.10 million

3-Year Low

$3.50 M
IRMD quarterly EBITDA is currently +65.90% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
IRMD previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 2, 2025
IRMD next earnings announcement is scheduled for May 2, 2025

OtherIRMDprofitabilitymetrics:

Quarterly Revenue

$19.39 M
IRMD quarterly revenue is $19.39 million

Quarterly Net Income

$5.15 M
IRMD quarterly net profit is $5.15 million

Quarterly EBIT

$5.80 M
IRMD quarterly earnings before interest & taxes is $5.80 million

Quarterly EPS

$0.40
IRMD quarterly earnings per share is $0.40

TTM EBITDA

$22.59 M
+$435.00 K+1.96%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

IRMD TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

82.53%
IRMD TTM EBITDA is higher than 82.53% of companies in Healthcare sector

High & Low

All-time High

$22.59 M
IRMD TTM EBITDA is currently at an all-time high

3-Year Low

$11.22 M
IRMD TTM EBITDA is currently +101.23% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
IRMD previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 2, 2025
IRMD next earnings announcement is scheduled for May 2, 2025

OtherIRMDprofitabilitymetrics:

TTM Revenue

$73.24 M
IRMD TTM revenue is $73.24 million

TTM Net Income

$19.23 M
IRMD TTM net profit is $19.23 million

TTM EBIT

$21.96 M
IRMD TTM earnings before interest & taxes is $21.96 million

TTM EPS

$1.50
IRMD TTM earnings per share is $1.50

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$21.96 M
IRMD annual EBITDA is $21.96 million

Annual Net Income

$19.23 M
IRMD annual net profit is $19.23 million

Annual Interest Expense

-
IRMD annual interest expense value is unknown

Annual Income Tax

$5.04 M
IRMD annual income tax is $5.04 million

Annual D&A

-
IRMD annual depreciation & amortization value is unknown

IRMD EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+5.6%0.0%0.0%
3 y3 years+95.7%0.0%0.0%
5 y5 years+122.1%0.0%0.0%

IRMD EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+95.7%-4.8%+65.9%at high+101.2%
5 y5-yearat high+3669.5%-4.8%+322.6%at high+3777.0%
alltimeall timeat high+3669.5%-4.8%+322.6%at high+3777.0%

IRadimed EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
$21.96 M(+5.6%)
$5.80 M(-3.1%)
$22.59 M(+2.0%)
Sep 2024
-
$5.99 M(+2.8%)
$22.15 M(-0.5%)
Jun 2024
-
$5.83 M(+17.1%)
$22.26 M(+3.1%)
Mar 2024
-
$4.97 M(-7.3%)
$21.59 M(+3.8%)
Dec 2023
$20.80 M(+27.6%)
$5.37 M(-12.0%)
$20.80 M(+5.6%)
Sep 2023
-
$6.10 M(+18.3%)
$19.69 M(+8.4%)
Jun 2023
-
$5.15 M(+22.9%)
$18.16 M(+2.8%)
Mar 2023
-
$4.19 M(-1.5%)
$17.67 M(+4.0%)
Dec 2022
$16.30 M(+45.2%)
$4.25 M(-6.9%)
$16.99 M(+4.7%)
Sep 2022
-
$4.57 M(-2.0%)
$16.23 M(+7.6%)
Jun 2022
-
$4.66 M(+32.8%)
$15.09 M(+19.6%)
Mar 2022
-
$3.51 M(+0.4%)
$12.62 M(+12.5%)
Dec 2021
$11.22 M(+1826.3%)
$3.50 M(+2.0%)
$11.22 M(+28.7%)
Sep 2021
-
$3.43 M(+56.3%)
$8.72 M(+36.1%)
Jun 2021
-
$2.19 M(+4.0%)
$6.41 M(+298.1%)
Mar 2021
-
$2.11 M(+113.0%)
$1.61 M(+176.2%)
Dec 2020
$582.70 K(-94.1%)
$990.00 K(-11.3%)
$582.60 K(-72.4%)
Sep 2020
-
$1.12 M(-142.8%)
$2.11 M(-44.5%)
Jun 2020
-
-$2.61 M(-340.8%)
$3.80 M(-58.1%)
Mar 2020
-
$1.08 M(-57.1%)
$9.07 M(-8.3%)
Dec 2019
$9.89 M(+39.1%)
$2.52 M(-10.3%)
$9.89 M(+5.0%)
Sep 2019
-
$2.81 M(+5.5%)
$9.42 M(+16.6%)
Jun 2019
-
$2.66 M(+40.0%)
$8.08 M(+7.8%)
Mar 2019
-
$1.90 M(-7.4%)
$7.49 M(+5.4%)
DateAnnualQuarterlyTTM
Dec 2018
$7.11 M(+174.1%)
$2.05 M(+40.3%)
$7.11 M(+11.2%)
Sep 2018
-
$1.46 M(-29.6%)
$6.39 M(+17.0%)
Jun 2018
-
$2.08 M(+37.1%)
$5.46 M(+34.6%)
Mar 2018
-
$1.52 M(+13.3%)
$4.06 M(+56.5%)
Dec 2017
$2.59 M(-78.2%)
$1.34 M(+150.5%)
$2.59 M(-13.7%)
Sep 2017
-
$534.00 K(-20.7%)
$3.01 M(-46.8%)
Jun 2017
-
$673.30 K(+1282.5%)
$5.65 M(-32.6%)
Mar 2017
-
$48.70 K(-97.2%)
$8.38 M(-29.4%)
Dec 2016
$11.88 M(-3.6%)
$1.75 M(-44.9%)
$11.88 M(-15.9%)
Sep 2016
-
$3.18 M(-6.5%)
$14.12 M(-0.6%)
Jun 2016
-
$3.40 M(-4.0%)
$14.20 M(+4.8%)
Mar 2016
-
$3.54 M(-11.3%)
$13.55 M(+10.0%)
Dec 2015
$12.32 M(+283.2%)
$4.00 M(+22.6%)
$12.32 M(+43.3%)
Sep 2015
-
$3.26 M(+18.6%)
$8.60 M(+48.5%)
Jun 2015
-
$2.75 M(+18.7%)
$5.79 M(+23.6%)
Mar 2015
-
$2.32 M(+742.7%)
$4.69 M(+45.8%)
Dec 2014
$3.21 M(+9.9%)
$274.80 K(-39.1%)
$3.21 M(-13.2%)
Sep 2014
-
$451.50 K(-72.5%)
$3.70 M(+1.7%)
Jun 2014
-
$1.64 M(+94.6%)
$3.64 M(+29.6%)
Mar 2014
-
$844.90 K(+10.6%)
$2.81 M(-4.0%)
Dec 2013
$2.93 M(+91.1%)
$763.90 K(+96.6%)
$2.93 M(+35.3%)
Sep 2013
-
$388.60 K(-52.2%)
$2.16 M(+21.9%)
Jun 2013
-
$812.90 K(-15.4%)
$1.77 M(+84.6%)
Mar 2013
-
$960.80 K
$960.80 K
Dec 2012
$1.53 M
-
-

FAQ

  • What is IRadimed annual EBITDA?
  • What is the all time high annual EBITDA for IRadimed?
  • What is IRadimed annual EBITDA year-on-year change?
  • What is IRadimed quarterly EBITDA?
  • What is the all time high quarterly EBITDA for IRadimed?
  • What is IRadimed quarterly EBITDA year-on-year change?
  • What is IRadimed TTM EBITDA?
  • What is the all time high TTM EBITDA for IRadimed?
  • What is IRadimed TTM EBITDA year-on-year change?

What is IRadimed annual EBITDA?

The current annual EBITDA of IRMD is $21.96 M

What is the all time high annual EBITDA for IRadimed?

IRadimed all-time high annual EBITDA is $21.96 M

What is IRadimed annual EBITDA year-on-year change?

Over the past year, IRMD annual EBITDA has changed by +$1.16 M (+5.60%)

What is IRadimed quarterly EBITDA?

The current quarterly EBITDA of IRMD is $5.80 M

What is the all time high quarterly EBITDA for IRadimed?

IRadimed all-time high quarterly EBITDA is $6.10 M

What is IRadimed quarterly EBITDA year-on-year change?

Over the past year, IRMD quarterly EBITDA has changed by $0.00 (0.00%)

What is IRadimed TTM EBITDA?

The current TTM EBITDA of IRMD is $22.59 M

What is the all time high TTM EBITDA for IRadimed?

IRadimed all-time high TTM EBITDA is $22.59 M

What is IRadimed TTM EBITDA year-on-year change?

Over the past year, IRMD TTM EBITDA has changed by $0.00 (0.00%)